Cell therapy for drug-resistant temporal lobe epilepsy
Part of Brain & nervous system clinical trials.
This trial tests a new cell-based treatment for people with epilepsy that has not improved with standard medications. The treatment aims to reduce seizures in patients with a specific type of epilepsy originating from one side of the brain.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 75 years old.
- You have had epilepsy for at least 2 years, and it has not been controlled by at least two anti-seizure medications.
- You have seizures that start in the temporal lobe (the side of the brain) and are not controlled by current medications.
- You have at least 4 seizures per month (on average) over the last 3 months.
- You are on a stable dose of your current seizure medications for at least 1 month before joining.
- You have adequate organ function (kidneys, liver, blood counts) as determined by blood tests.
- You have not had brain surgery for epilepsy, and you do not have any metal or electronic implants in your skull or brain.
- You are willing to use effective birth control and not plan pregnancy or donate sperm/eggs for 2 years after the treatment.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new cell therapy, UX-GIP001, for people whose seizures start in one small area of the brain (the mesial temporal lobe) and are not controlled by at least two seizure medications. The goal is to see if this treatment can safely reduce seizures.
This trial tests a brain stimulation treatment for people with temporal lobe epilepsy that doesn't improve with medication. The goal is to see if it can reduce seizures.
This trial is testing a new treatment made from human stem cells to see if it is safe and helpful for people whose seizures are not controlled by current medications. If you have drug-resistant epilepsy, this treatment might offer a new option.
This trial uses detailed brain tests to better match people with epilepsy to the right treatment. It may help by using “precision medicine” methods to understand what in the brain is driving seizures.
This study tests a new way to treat seizures that start in the temporal lobe using special electrical signals that focus on the seizure area without surgery. It may help reduce seizures in people whose seizures don't stop with medicine.
This Phase 2 trial tests SPN-817 in adults whose seizures are still not well controlled despite trying multiple seizure medicines. It targets people with a specific type of brain finding called focal cortical dysplasia and looks at safety/tolerability and seizure outcomes over several weeks.
Hear when a new Epilepsy trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.